**Pharmaceutical Services Issue Warning on Unlicensed Medications**
The pharmaceutical services of the Ministry of Health in Cyprus have issued a significant warning regarding the dangers associated with the use of unauthorized and illegally traded medications. In a statement released on Monday, the authorities highlighted the serious health risks these products pose to users, particularly those marketed for muscle growth, aesthetic enhancement, and overall health improvement.
The warning specifically addresses a range of products that claim to enhance physical appearance, wellbeing, and health, including various hormones and other substances available in both injectable and oral forms. The authorities emphasized that the mere marketing of these products as safe does not exempt them from compliance with existing pharmaceutical regulations.
"The use of such claims and indications on products intended for human use is misleading and does not exempt them from compliance with current pharmaceutical legislation," the statement read. This assertion underscores the potential hazards of using medications that have not undergone the rigorous testing and approval processes mandated by health authorities.
Injectable and intravenous products are of particular concern, as their administration bypasses the body's natural defense mechanisms. The pharmaceutical services warned that improperly manufactured, stored, or distributed products could lead to contamination, the presence of unknown or incorrect active substances, incorrect dosages, and serious adverse reactions, including infections and toxicity.
To ensure the safety and efficacy of medicinal products, the authorities stressed the importance of sourcing medications exclusively from legal and regulated channels. They reiterated that all medications should be dispensed only through authorized pharmacies and with a valid prescription. "Only through the established control system can the required quality, safety, and efficacy of medicines be guaranteed," the statement noted.
The warning also addressed the legal implications of selling unauthorized and unapproved medical products. The pharmaceutical services indicated that engaging in such activities would violate applicable legislation and could result in penalties for those involved.
In light of these concerns, the public is strongly advised against purchasing or using medicinal products from unauthorized sources, including the internet or unregulated individuals. The authorities cautioned that even products marketed as "innovative," "natural," "safe," "side-effect-free," or designated "for research use only" should be approached with skepticism.
This warning comes amid growing concerns over the proliferation of unregulated medications in various markets, which can pose significant risks to public health. The pharmaceutical services are urging citizens to remain vigilant and to prioritize their health by ensuring that any medications they use are obtained from legitimate and trustworthy sources.
As the landscape of pharmaceutical products continues to evolve, the Ministry of Health's pharmaceutical services remain committed to safeguarding public health and ensuring that all medications meet the required safety and efficacy standards.